Objective-Abdominal aortic aneurysms (AAAs), dilations of the infrarenal aorta, are characterized by inflammation and oxidative stress. We previously showed increased levels of peroxiredoxin-1 (PRDX-1) in macrophages cultured from AAA patients. The purpose of the study was to determine which subpopulation of macrophages is present in AAAs and is involved in upregulation of PRDX-1 in aneurysmal disease. Methods and Results-This study used immunohistochemistry with antibodies against CD68 and mannose receptor (MR) to determine the subtype of macrophages in AAA tissue samples (n=33 
A bdominal aortic aneurysm (AAA) is a vascular disease that is one of the leading causes of death in developed countries 1 ; these aneurysms are characterized by dilation of the infrarenal aorta with a diameter >30 mm and, often, by the formation of an intraluminal thrombus. Known risk factors for AAA are advanced age, male sex, cigarette smoking, hypertension, genetic susceptibility, and atherosclerosis at another site. 2 In men >65 years, its prevalence is 5% and ruptures are responsible for 1% to 4% of total mortality in this population, largely because it is asymptomatic before rupture. 3, 4 Few prognostic determinants for AAA have been identified, and the major predictor of AAA rupture in current use is aortic diameter. 5 Identifying biomarkers for AAA that can be detected easily in blood, before rupture, could be extremely useful by enabling systematic screening of the population at risk. These biomarkers might also suggest possible targets for new medical treatments to slow AAA progression. 5 Many studies have sought to investigate the mechanisms involved in AAA to identify such biomarkers. Comparative analysis of plasma and blood from AAA and control patients with healthy aortas has identified some proteins as potentially relevant biomarkers. 6, 7 Plasma is a very complex sample, however, with 14 different major proteins accounting for 99% of the plasma proteome. Other studies have investigated cultured AAA cells from human patients. 8 The secretome, proteome, or transcriptome might also be good targets for identifying biomarkers, either from whole-aorta tissue [9] [10] [11] [12] [13] or from the AAA-separated layers. 14, 15 However, because AAA is a complex disease, and aneurysmal tissue is similarly complex, proteomic analyses of whole-organ AAA tissue can hide cell-specific targets. Sho et al 16 reported that analysis for cell types in an experimental rat model of AAA reveals specific cellular responses to inflammation that are not shown on whole-aorta tissue. Laser 
Conclusion-These findings suggest that the proteins or mRNAs expressed by the proinflammatory CD68 February 2013
useful technique for isolating specific areas or cell types from complex tissues, without any of the phenotypic modifications that can occur during cell culture. Nucleic acids or proteins can then be extracted from the collected samples and used for either gene expression 17 or proteomic 18 analyses. Studies of human tissues have identified extensive inflammatory infiltrates 19 and indicate that inflammation is a key factor in aneurysmal pathology. Numerous inflammatory cells are involved in AAA formation and growth, 20, 21 among them, macrophages. 22, 23 Interestingly, the 2 subtypes of macrophages, M1 and M2, have opposite functions: the M1 subtype has proinflammatory properties and the M2 subtype has anti-inflammatory properties. 24 Chinetti-Gbaguidi et al 17 have demonstrated the differential involvement of these 2 subtypes in human atherosclerotic plaques. Recently, the aneurysmal aortic segments in Apoe −/− mice infused with angiotensin II were found to accumulate M2 macrophages at rupture sites. 25 Two independent groups using proteomic analysis have discovered that peroxiredoxin-1 (PRDX-1) might be a biomarker for AAA. 8, 12 More precisely, Lamblin et al 8 showed that PRDX-1 is expressed by monocyte-derived macrophages. Studying the 2 macrophage subtypes in human AAA might, therefore, improve our understanding of their role in this disease and help to identify potential biomarkers secreted by these cells into the blood circulation.
In this study, we identified both M1 and M2 macrophages in different layers of the AAA tissue, isolated these layers by LCM, and characterized their specific M1 or M2 protein or gene expression by Western blot and quantitative-reverse transcriptase-polymerase chain reaction (q-RT-PCR). We also evaluated the expression of matrix metalloproteinase (MMP)9 in both subtypes, as macrophages are the primary source of this MMP in human AAA tissue. 26 We then analyzed the macrophage subtype involved in upregulation of PRDX-1 in AAA disease. Molecular analysis of the 2 macrophage subtypes in AAA with their pro-and anti-inflammatory properties improves our understanding of the pathophysiological mechanisms of this disease. Identification of new targets or proteins secreted by proinflammatory macrophages may be a new and useful approach for selecting circulating biomarkers that can help to predict the progression of AAA.
Materials and Methods

Population Study
Samples of human aneurysmal infrarenal aortic wall were obtained from 33 patients in Pr Haulon's vascular surgery unit at the University Hospital Center (Lille, France) during open aortic repair of unruptured aneurysms >50 mm. Thirteen samples were snap-frozen in liquid nitrogen directly after the surgery. Twenty samples, each with an intraluminal thrombus, were collected in normal saline solution at 4°C. All of the latter samples were dissected into transversal slides after orientation of the tissue by macroscopic analysis. Sections were either formalin-fixed and paraffin-embedded or snap-frozen in liquid nitrogen. Our study conformed to the principles outlined in the Declaration of Helsinki. We obtained informed consent in writing from each patient undergoing open surgery and recovered the biopsy samples as surgical waste but without any information about the patients, in accordance with French laws on medical ethics. This population was used for histological, immunohistochemical, and LCM analyses of macrophages present in the human aneurysmal infrarenal aortic wall. (8-µm) were fixed in 4% paraformaldehyde (Sigma-Aldrich) and permeabilized in 0.1% triton X-100 (Hopkins & Williams, London, England). After the sections were blocked in 1% bovine serum albumin (Interchim, Montluçon, France) for 30 minutes, they were incubated with primary anti-CD68 (1/50), anti-MR (1/50), anti-PRDX-1 (1/500), and anti-MMP9 (1/500) antibodies for 2 hours at room temperature. After they were washed with PBS 1X (BioMérieux, Marcy l'Etoile, France), they were incubated with the appropriate secondary antibody (1/300) antimouse conjugated with Alexa 488 or 555, antigoat conjugated with Alexa 488 or antirabbit conjugated with Alexa 555 (Invitrogen, Life technologies, Saint Aubin, France) for 30 minutes at room temperature. Hoechst reagent (1/50000, Invitrogen) was then added for 10 minutes to enable visualization of the nuclei. Slides were finally mounted with Glycergel and analyzed with an Axioimager Z1 Aplotome system with an MRm Rev3 AxioVision-Deconvolution 3-dimensional camera (Zeiss). See Table I in the online-only Data Supplement for more information about the antibodies.
Staining
Laser Capture Microdissection
Frozen sections (8-µm) were stained with Oil-Red O until cellular zones were detected. The adjacent sections were then stained for CD68 and MR to identify the areas with abundant M1 ( 
Cell Culture
Human peripheral blood mononuclear cells were isolated from healthy donors by Ficoll density gradient centrifugation. 27 Monocyte differentiation to macrophages was induced by 6 days of culture in Roswell Park Memorial Institute 1640 medium (Invitrogen) supplemented with gentamicin (40 µg/mL; Invitrogen), L-glutamine (2 mmol/L; Sigma-Aldrich), and 10% pooled human serum (Abcys, Eurobio, Courtaboeuf, France). Addition of lipopolysaccharides (100 ng/mL; Sigma-Aldrich) for 4 hours at the end of differentiation produced M1-oriented macrophages, and the presence of recombinant human interleukin 4 (15 ng/mL; Promocell, Heidelberg, Germany) for all 6 days led to M2-oriented macrophages.
Protein Extraction and Western Blot Analyses
LCM-dissected areas rich in CD68 + MR − and CD68 + MR + macrophages were incubated for 10 minutes in radio immunoprecipitation assay buffer (Tris 50 mmol/L, NaCl 50 mmol/L, Igepal 1%, sodium deoxycholate 10 mmol/L, SDS 0.1%, sodium orthovanadate 100 mmol/L, from Sigma-Aldrich) and protease inhibitor cocktail (1 tablet/10 mL of radio immunoprecipitation assay buffer, Roche Diagnostics, France), then mixed for 10 minutes and sonicated for 5 minutes. The protein concentrations were measured by Bradford assays (Bio-Rad, Marnes-la-Coquette, France) and the extracts stored at −20°C until further analysis.
The proteins (50 µg) extracted from the separate CD68 + MR − and CD68 + MR + macrophage-rich areas were reduced with dithiothreitol (Bio-Rad) 0.2 mol/L for 10 minutes at 90°C and then loaded on a 15% polyacrylamide gel (Bio-Rad). After separation, they were transferred onto a 45-µm hybrid nitrocellulose membrane (GE Healthcare, Velizy-Villacoublay, France) for 1 hour at 30 V. Ponceau red (SigmaAldrich) staining of the membranes and scanning provided visual verification of total protein loads. After being blocked for 1 hour in 5% nonfat-dried milk (Dominique Dutscher, Brumath, France), the membranes were incubated overnight with either rabbit polyclonal antistabilin 1 (1/100, Santa Cruz Biotechnology), rabbit polyclonal antihemoglobin (1/3000, Sigma-Aldrich), or rabbit polyclonal anti-PRDX-1 (1/500, Abcam) antibodies. Detailed information about the antibodies is provided in Table I in the online-only Data Supplement.
After being washed with tris-buffered saline-Tween (Tris 100 mmol/L, NaCl 150 mmol/L, Tween 0.1%, Sigma-Aldrich), the membranes were incubated with donkey antirabbit antibody conjugated with horseradish peroxidase (1/5000, GE Healthcare) for 1.5 hours. Detection was performed with an enhanced chemiluminescence Western blotting detection reagent (ECL plus; GE Healthcare), followed by membrane scanning with an Ettan DIGE Imager Scanner (GE Healthcare) at excitation or emission wavelengths of 480 nm or 530 nm, which yielded images with a pixel size of 100 µm.
RNA Extraction and q-RT-PCR Analyses
Total cellular RNA was extracted from cultured macrophages with Trizol (Life Technologies, Saint Aubin, France) and from LCMdissected areas with the PicoPure RNA Extraction Kit (MDS Analytical Technologies) according to the instructions of the manufacturer. RNA quality was checked with RNA Pico Chips (Agilent Technologies, Massy, France) and a bioanalyzer (Agilent 2100 Bioanalyzer, Agilent Technologies). Sample RNA integrity was considered sufficient if the RNA integrity number was close to ≥5. RNA from LCM-dissected areas was then amplified in 2 rounds with the ExpressArt TRinucleotide mRNA amplification Nano kit (AMSBiotechnology, Abingdon, United Kingdom).
Amplified RNA was reverse-transcribed into cDNA with random hexamer primers and the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Life technologies, Saint Aubin, France). Q-PCR analyses were performed with the Brilliant SYBR Green QPCR Master Mix (Agilent Technologies) on an Mx3000P Q-PCR System (Agilent Technologies). The macrophage subpopulations were characterized according to their expression of the following genes: TNF, IL1B, CCL18, MRC1, PRDX-1, and MMP9. We used PPIA as a reference gene. Primer sequences are shown in Table II 
Statistical Analysis
For experimental data, statistical differences between groups for q-RT-PCR in cultured macrophages were analyzed by the MannWhitney U test and considered significant when P<0.05. 
Results
Distribution of M1 (CD68
Macrophages in the Human Aneurysmal Aortic Wall
The aim of this study was to determine whether different macrophage subpopulations are present in human aneurysmal aortas and to study their distribution. We used 2 antibodies to characterize the different subtypes: 1 recognizes the CD68 antigen, which is a pan-macrophage marker 28 and, thus, present in both M1 and M2, and the other recognizes the CD206 antigen, the MR encoded by the MRC1 gene, the most highly induced marker of M2 macrophages. 29 Histological staining was performed to characterize these macrophages for iron deposits (Perls-Van Gieson staining) and cell size (May-Grunwald staining). Figure I in the online-only Data Supplement summarizes the experimental procedure used to identify, locate, and isolate the 2 subtypes of macrophages in each AAA sample collected. First, 20 AAA samples collected in saline solution were macroscopically analyzed to orient and dissect them; they were then analyzed by immunohistochemistry to detect and locate the cells of interest. Before further molecular analysis, 13 different AAA samples, snap-frozen on collection, were used for LCM of areas rich in each macrophage subtype. Our results show that each subtype of macrophage is specifically distributed in relation to the aneurysmal aortic wall. Not every AAA tissue sample contained both types of macrophage: the individual AAA samples were heterogeneous from patient to patient and might have varied according to disease complexity, as suggested in Table IIIA Frozen samples of AAA tissue were systematically immunostained for CD68 and MR to locate areas of abundance for each macrophage subtype (Figure 2A ). To avoid any contamination, we selected sample sections on which no other inflammatory cell types or smooth muscle cells were visualized. Once the areas were located on the frozen samples, adjacent thicker sections were used for microdissection of the separate areas specifically abundant in CD68 Phenotypic characterization was performed by Western blot ( Figure 2B ) and q-RT-PCR ( Figure 2C) Figure 2B , band at 87 kDa). This finding thus confirmed that LCM had isolated the appropriate macrophage subtypes correctly. 31 We also found that both subtypes of macrophages contained hemoglobin ( Figure 2B , band at 15 kDa), as expected in view of their involvement in hemorrhage clearance. 32 We then used q-RT-PCR to investigate the mRNA levels of both the proinflammatory cytokines, TNF and IL1B, and of markers of alternative macrophage polarization, MRC1 and CCL18, in the LCM-isolated CD68 Figure  2C ) and compared them with the cultured macrophages differentiated into M1 or M2 from healthy donors ( Figure 2D ). As expected, the expression profile of these genes was similar for each macrophage subtype, whether it was isolated by LCM in AAA tissue or obtained in vitro: the proinflammatory 
Macrophages Isolated by LCM
We looked at the localization of PRDX-1 expression in the AAA samples to test our hypothesis that the 2 macrophage subtypes expressed PRDX-1 differentially. The stained CD68 + MR − macrophages and PRDX-1 were located in similar sites in AAA transversal sections ( Figure 3A) . Using immunofluorescence to confirm this result, we found that the macrophages stained with anti-CD68 (red) and PRDX-1 (green; Figure 3B , upper panels) were colocalized. As a control experiment, we tested for PRDX-1 expression in MR-positive stained macrophages and found none ( Figure These results confirm that PRDX-1 is specifically expressed by MR-negative stained macrophages. Interestingly, immunofluorescence showed colocalization of macrophages stained with anti-CD68 (red) and MMP9 (green; Figure 3B , lower panels), but did not discriminate between the 2 subtypes: MMP9 was detected in MR-positive ( Figure IIA Further confirmation that PRDX-1 is specifically expressed in CD68 + MR − macrophages came from a comparison of the levels Figure 3C, middle lower panel) . The antibody used to detect MMP9 has been described, detecting both the latent and active form, but we cannot exclude a difference of specificity for recognizing the 2 forms of MMP9.
Discussion
Although aneurysms may develop throughout the length of the aorta, they are at least 5× more prevalent in the abdomen than in the thorax, mainly because of the susceptibility of vascular smooth muscle cells, and differential hemodynamic influences. 33 The pathological features of aneurysms are oxidative stress, inflammation, matrix degradation, and smooth muscle cells apoptosis, 34 occurring mainly in aortic media and adventitia. 35 The aneurysmal aortic wall is a complex tissue composed of different cell types (eg, inflammatory cells and smooth muscle cells) at different times during the disease course. 36 Inflammation is not only associated with the clinical presence of AAA, but also plays a key role in its pathogenesis. 25 that showed an accumulation of macrophages expressing MR at rupture sites in Apoe −/− mice infused with angiotensin II. As previously reported, AAA develops from a combination of events that release reactive oxygen species and induce oxidative stress. 37 This leads to the activation of the proinflammatory M1 macrophages, which absorb the cell debris, turn into foam cells, 38 and thereby create more oxidative stress, thus potentiating the cycle and reinforcing AAA development. 37 At the same time, M2 anti-inflammatory macrophages fight this autoimmune response by regulating the presence of unwanted-self cells; a mechanism that suggests that AAA is also an immunologic disease. 39 The implications of these contradictory functions that macrophages can develop are significant. Molecular analysis or phenotyping of areas rich in specific macrophage subpopulations may be useful for understanding AAA disease. We postulated that macrophage heterogeneity and subset localization in AAA tissue are not attributable to the simple transition to specific monocyte subtypes, 40 41 This ability is especially important for complex tissue, such as the aneurysmal wall. 16, 42 The areas abundant in macrophages were characterized by immunostaining with specific antibodies against each subtype and by Perls-Van Gieson staining, which showed more intense iron deposits in M2 (CD68 + MR + ) than in M1 (CD68 + MR − ) macrophages. As recently shown, M2 macrophages display a phenotype associated with a higher capacity for heme uptake and nonheme iron release, whereas M1 macrophages have a phenotype associated with iron sequestration. 43 The presence of hemoglobin in LCM-isolated cells confirmed that the cells isolated were indeed macrophages, and these cells are involved in hemorrhage clearance. 32 We validated the accuracy of LCM in isolating specific subtypes of macrophages by comparing the expression of 4 genes (TNF, IL1B, MRC1, and CCL18) that have been previously described as differentially expressed in the 2 subtypes of macrophages. 17 We found similar expression profiles in both cultured and LCM-isolated macrophages. We also found that stabilin 1, involved in the uptake and degradation of unwanted-self molecules, 31 
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− proinflammatory macrophages by experiments of colocalization in aneurysmal aorta tissue. This finding is consistent with the involvement of PRDX-1 in oxidative stress, which is more likely to be expressed in macrophages of the M1 proinflammatory subtype. Oxidative stress attributable to reactive oxygen species production is known to be elevated in AAA and is indeed 1 of its major features. 44 It is also involved in the inflammatory response. 37 Recently, we reported upregulation in the plasma of AAA patients of extracellular superoxide dismutase, 7 an enzyme involved in superoxide metabolic processes that protect the extracellular space from reactive oxygen species.
Our results suggest that the upregulation of PRDX-1, previously found in the plasma of AAA patients, 15 originates from proinflammatory CD68 + MR − macrophages in the aneurysmal tissue. These CD68 + MR − macrophages may, thus, be contributing to the development of oxidative stress, which is associated with AAA formation in humans. 37 In contrast, MMP9 was not specifically expressed by the proinflammatory CD68 + MR − macrophages. In the past, MMP9 has been described as an effective monitor of endovascular grafts to treat AAA, 45 but recently, despite attenuation of development of AAA in Apoe −/− mice infused with angiotensin Il by rice extract, MMP9 levels were not found to have changed at all in either the serum or aortic wall. ) macrophages thus appears to be a useful and novel strategic approach for screening and identifying other circulating markers of AAA. When identified, such biomarkers will not only require validation in large population with different control groups (healthy, atherosclerotic, atherothrombotic, cardiovascular risk factors) but also the analysis of sex differences in AAA patients. 47 
